Center For Financial Planning, Inc. Neurocrine Biosciences Inc Transaction History
Center For Financial Planning, Inc.
- $748 Million
- Q4 2024
A detailed history of Center For Financial Planning, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Center For Financial Planning, Inc. holds 11 shares of NBIX stock, worth $1,243. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11Holding current value
$1,243% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
655Shares Held
96.6MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.6 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.14 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$553 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$341 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$287 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.8B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...